Raymond Cohen Purchases 17,000 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock

Key Points

• Raymond Cohen, a director at Kestra Medical Technologies, purchased 17,000 shares of the company for a total of $289,000, increasing his ownership by 130.83%.
• Kestra Medical Technologies' stock is currently trading at approximately $17.86, with a 52-week range between $13.25 and $26.15.
• Wells Fargo & Company has reduced its target price for the stock from $28.00 to $27.00, while five investment analysts maintain a buy rating on the stock.

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) Director Raymond Cohen bought 17,000 shares of the company's stock in a transaction that occurred on Friday, March 7th. The shares were bought at an average price of $17.00 per share, for a total transaction of $289,000.00. Following the transaction, the director directly owned 29,994 shares in the company, valued at $509,898. This trade represents a 130.83% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Kestra Medical Technologies Stock Performance

Kestra Medical Technologies stock traded up $0.86 during midday trading on Monday, reaching $17.86. The stock had a trading volume of 295,376 shares, compared to its average volume of 194,231. The company has a debt-to-equity ratio of 0.20, a current ratio of 6.72 and a quick ratio of 6.72. Kestra Medical Technologies, Ltd. has a 12 month low of $13.25 and a 12 month high of $26.15. The business has a fifty day moving average price of $16.18.

Institutional Trading of Kestra Medical Technologies

Hedge funds and other institutional investors have recently modified their holdings of the business. Quarry LP bought a new position in shares of Kestra Medical Technologies in the first quarter worth $33,000. Police & Firemen s Retirement System of New Jersey purchased a new stake in Kestra Medical Technologies during the 2nd quarter worth about $54,000. New York State Common Retirement Fund bought a new position in Kestra Medical Technologies in the 2nd quarter worth about $93,000. Virtu Financial LLC purchased a new position in Kestra Medical Technologies during the 1st quarter valued at about $210,000. Finally, Walleye Capital LLC bought a new stake in shares of Kestra Medical Technologies during the second quarter valued at about $166,000.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company reduced their target price on Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a report on Thursday, July 17th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $27.33.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.